Glycanostics has become a member of the Oslo Cancer Cluster (OCC), an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment.

The Oslo Cancer Cluster’s mission is to help get the right treatment to the right patient at the right time.

Glycanostics is highly dedicated to this mission. We look forward to participating in OCC projects to shape the diagnostics future for oncological patients. Collaboration with cluster members and international cluster partners can drive our mission faster and share Glycanostics’ vision.